DE19944604A1 - Aminderivate - Google Patents

Aminderivate

Info

Publication number
DE19944604A1
DE19944604A1 DE19944604A DE19944604A DE19944604A1 DE 19944604 A1 DE19944604 A1 DE 19944604A1 DE 19944604 A DE19944604 A DE 19944604A DE 19944604 A DE19944604 A DE 19944604A DE 19944604 A1 DE19944604 A1 DE 19944604A1
Authority
DE
Germany
Prior art keywords
formula
atoms
benzo
replaced
thieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19944604A
Other languages
German (de)
English (en)
Inventor
Volker Eiermann
Rochus Jonas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE19944604A priority Critical patent/DE19944604A1/de
Priority to CZ2002817A priority patent/CZ2002817A3/cs
Priority to EP00962374A priority patent/EP1212329A2/de
Priority to BR0014052-0A priority patent/BR0014052A/pt
Priority to AU74127/00A priority patent/AU7412700A/en
Priority to PL00353319A priority patent/PL353319A1/xx
Priority to PCT/EP2000/008256 priority patent/WO2001021620A2/de
Priority to JP2001524996A priority patent/JP2003509511A/ja
Priority to KR1020027003415A priority patent/KR20020027652A/ko
Priority to CA002387520A priority patent/CA2387520A1/en
Publication of DE19944604A1 publication Critical patent/DE19944604A1/de
Priority to NO20021310A priority patent/NO20021310D0/no
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19944604A 1999-09-17 1999-09-17 Aminderivate Withdrawn DE19944604A1 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DE19944604A DE19944604A1 (de) 1999-09-17 1999-09-17 Aminderivate
PL00353319A PL353319A1 (en) 1999-09-17 2000-08-24 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines
EP00962374A EP1212329A2 (de) 1999-09-17 2000-08-24 Aminderivate von benzo[4,5]thieno[2,3-d]pyrimidinen
BR0014052-0A BR0014052A (pt) 1999-09-17 2000-08-24 Derivados de aminas
AU74127/00A AU7412700A (en) 1999-09-17 2000-08-24 Amine derivatives
CZ2002817A CZ2002817A3 (cs) 1999-09-17 2000-08-24 Derivát aminu
PCT/EP2000/008256 WO2001021620A2 (de) 1999-09-17 2000-08-24 Aminderivate von benzo-4,5-thieno-2,3-d-pyrimidinen
JP2001524996A JP2003509511A (ja) 1999-09-17 2000-08-24 アミン誘導体
KR1020027003415A KR20020027652A (ko) 1999-09-17 2000-08-24 아민 유도체
CA002387520A CA2387520A1 (en) 1999-09-17 2000-08-24 Amine derivatives
NO20021310A NO20021310D0 (no) 1999-09-17 2002-03-15 Aminderivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19944604A DE19944604A1 (de) 1999-09-17 1999-09-17 Aminderivate

Publications (1)

Publication Number Publication Date
DE19944604A1 true DE19944604A1 (de) 2001-03-22

Family

ID=7922374

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19944604A Withdrawn DE19944604A1 (de) 1999-09-17 1999-09-17 Aminderivate

Country Status (11)

Country Link
EP (1) EP1212329A2 (pt)
JP (1) JP2003509511A (pt)
KR (1) KR20020027652A (pt)
AU (1) AU7412700A (pt)
BR (1) BR0014052A (pt)
CA (1) CA2387520A1 (pt)
CZ (1) CZ2002817A3 (pt)
DE (1) DE19944604A1 (pt)
NO (1) NO20021310D0 (pt)
PL (1) PL353319A1 (pt)
WO (1) WO2001021620A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148883A1 (de) 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
WO2003035653A1 (fr) * 2001-10-26 2003-05-01 Nippon Soda Co.,Ltd. Compose pyridothienopyrimidine et son sel
AR059901A1 (es) 2006-03-20 2008-05-07 Bayer Pharmaceuticals Corp Compuestos de tetrahidropiridotienopirimidina utiles para tratar o prevenir trastornos proliferativos celulares.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470356A1 (de) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
US5948911A (en) * 1998-11-20 1999-09-07 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
CN1346358A (zh) * 1999-03-30 2002-04-24 日本曹达株式会社 噻吩并嘧啶化合物及其盐和制备方法
DE19928146A1 (de) * 1999-06-19 2000-12-21 Merck Patent Gmbh Thienopyrimidine

Also Published As

Publication number Publication date
NO20021310L (no) 2002-03-15
WO2001021620A2 (de) 2001-03-29
AU7412700A (en) 2001-04-24
KR20020027652A (ko) 2002-04-13
CZ2002817A3 (cs) 2002-06-12
PL353319A1 (en) 2003-11-17
BR0014052A (pt) 2002-05-21
NO20021310D0 (no) 2002-03-15
EP1212329A2 (de) 2002-06-12
CA2387520A1 (en) 2001-03-29
JP2003509511A (ja) 2003-03-11
WO2001021620A3 (de) 2001-11-01

Similar Documents

Publication Publication Date Title
DE19644228A1 (de) Thienopyrimidine
EP1036078B1 (de) Thienopyrimidine
DE10058663A1 (de) Verwendung von Thienopyrimidinen
EP1189907B1 (de) Thienopyrimidine als phosphodiesterase hemmer
EP1084125B1 (de) Kondensierte thienopyrimidine mit pde v inhibierender wirkung
EP1210349B1 (de) Pyrazolo[4, 3-d]pyrimidine
DE10064994A1 (de) Sulfamidothienopyrimidine
DE10058662A1 (de) Verwendung von Pyrazolo[4,3-d]pyrimidinen
WO2002060449A2 (de) Pharmazeutische formulierung enthaltend pyrazolo[4,3-d]pyrimidine und nitrate oder thienopyrimidine und nitrate
DE19944604A1 (de) Aminderivate
DE10104802A1 (de) Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (1)
DE10060388A1 (de) Verwendung von Pyrazolo [4,3-d]pyrimidinen
EP1351962B1 (de) Thienopyrimidine
DE10010612A1 (de) Verwendung von PDE V-Inhibitoren
DE19943815A1 (de) Verwendung von Thienopyrimidinen
DE10104097A1 (de) Pharmazeutische Formulierung enthaltend Thienopyrimidine und Nitrate
DE10104096A1 (de) Pharmazeutische Formulierung enthaltend Thienopyrimidine und Nitrate
DE10064991A1 (de) Pharmazeutische Formulierung enthaltend Thienopyrimidine und Prostaglandine oder Prostaglandinderivate (2)
DE10104801A1 (de) Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (2)
DE10104095A1 (de) Pharmazeutische Formulierung enthaltend Pyrazolo [4,3-d]pyrimidine und Nitrate
DE10063885A1 (de) Pharmazeutische Formulierung enthaltend Thienopyrimidine und Calcium-Antagonisten (1)
DE10063884A1 (de) Pharmazeutische Formulierung enthaltend Thienopyrimidine und Calcium-Antagonisten (2)
DE10063882A1 (de) Pharmazeutische Formulierung enthaltend Pyrazolo[4,3-d]pyrimidine und Calcium-Antagonisten
DE10064992A1 (de) Pharmazeutische Formulierung enthaltend Thienopyrimidine und Prostaglandine oder Prostaglandinderivate (1)

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee